...
机译:BRAF,RAS BRAF,RAS和TERT TERT的分子检测具有不确定细胞学的甲状腺FNA上提高了诊断准确性
Pathology departmentCentre Hospitalier Lyon SudPierre Bénite France;
Biochemistry and molecular biology departmentCentre Hospitalier Lyon SudPierre Bénite France;
Pathology departmentCentre Hospitalier Lyon SudPierre Bénite France;
Radiology departmentCentre Hospitalier Lyon SudPierre Bénite France;
Radiology departmentCentre Hospitalier Lyon SudPierre Bénite France;
Endocrinology departmentGroupement hospitalier EstBron France;
Endocrine surgery departmentCentre Hospitalier Lyon SudPierre Bénite France;
Biochemistry and molecular biology departmentCentre Hospitalier Lyon SudPierre Bénite France;
indeterminate cytology; molecular testing; TERT promoter mutations; thyroid cancer; thyroid liquid‐based fine needle aspiration;
机译:BRAF,RAS BRAF,RAS和TERT TERT的分子检测具有不确定细胞学的甲状腺FNA上提高了诊断准确性
机译:细胞学上不确定的甲状腺结节中
机译:甲状腺液基细针穿刺对BRAF,RAS和TERT的突变分析可提高诊断准确性
机译:FDA批准的Thxidtm BRAF测试在医院分子实验室的比较评价
机译:Kanin过渡细胞和前列腺癌BRAF变体V595e对BRAF变体V595e的组织学,免疫组织学和分子遗传学研究=犬传递中BRAF变异V595E的组织学,免疫组织化学和分子遗传研究
机译:术前分子分析可部分克服不确定性甲状腺结节的细针抽吸(FNA)的诊断局限性:评估BRAF和RAS野生型常规空干FNA标本中的RET / PTC1重排
机译:通过术前分子分析可以部分地克服细针抽吸(FNA)对不确定的甲状腺结节的诊断限制:BRAF和RAS野生型常规风干FNA标本的RET / PTC1重排的评估